1997
DOI: 10.1159/000177973
|View full text |Cite
|
Sign up to set email alerts
|

Design of Parenteral Synthetic Dipeptides for Clinical Nutrition: In vitro and in vivo Utilization

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2000
2000
2017
2017

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 13 publications
(1 citation statement)
references
References 23 publications
0
1
0
Order By: Relevance
“…Hydrolase activities against these conjugates are considerably higher in rat mucosa and kidney homogenates than in plasma. 61,62 Additionally, in subcellular fractions of rat mucosa the hydrolase capacities of the brush border membrane vesicles and cytosol were at least 300-fold and 30-fold higher, respectively, than in plasma. The existence of considerable membrane-bound and intracellular hydrolase activity suggests that amino acid-taurine conjugates might be used as efficient sources of free taurine in clinical nutrition.…”
Section: Utilization Of Dipeptides: In Vitro Studiesmentioning
confidence: 97%
“…Hydrolase activities against these conjugates are considerably higher in rat mucosa and kidney homogenates than in plasma. 61,62 Additionally, in subcellular fractions of rat mucosa the hydrolase capacities of the brush border membrane vesicles and cytosol were at least 300-fold and 30-fold higher, respectively, than in plasma. The existence of considerable membrane-bound and intracellular hydrolase activity suggests that amino acid-taurine conjugates might be used as efficient sources of free taurine in clinical nutrition.…”
Section: Utilization Of Dipeptides: In Vitro Studiesmentioning
confidence: 97%